Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature

• Publication date

  2014-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature13537PMID 25043028PMCID PMC4110711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome recognition by MYC.

  2014cited by this paper
• Mechanisms by which transcription factors gain access to target sequence elements in chromatin.

  2013cited by this paper
• High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states

  2013cited by this paper
• MYC, metabolism, cell growth, and tumorigenesis.

  2013cited by this paper
• Global regulation of promoter melting in naive lymphocytes.

  2013cited by this paper
• Modification of enhancer chromatin: what, how, and why?

  2013cited by this paper
• Mechanistic interpretation of promoter-proximal peaks and RNAPII density maps.

  2013cited by this paper
• Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.

  2012cited by this paper
• c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

  2012cited by this paper
• Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.

  2012cited by this paper
• Revisiting global gene expression analysis.

  2012cited by this paper
• Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc

  2012cited by this paper
• Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics

  2012cited by this paper
• Transcriptional amplification in tumor cells with elevated c-Myc.

  2012cited by this paper
• Coordinating genome expression with cell size.

  2012cited by this paper
• Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells

  2011cited by this paper
• Charting histone modifications and the functional organization of mammalian genomes

  2011cited by this paper
• Integrating diverse genomic data using gene sets

  2011cited by this paper
• Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts

  2011cited by this paper
• The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

  2011cited by this paper
• Transcriptional repression: the dark side of myc.

  2010cited by this paper
• c-Myc regulates transcriptional pause release.

  2010cited by this paper
• Connecting Variability in Global Transcription Rate to Mitochondrial Variability

  2010cited by this paper
• A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates the B cell fate

  2010cited by this paper
• Time-Dependent c-Myc Transactomes Mapped by Array-Based Nuclear Run-On Reveal Transcriptional Modules in Human B Cells

  2010cited by this paper
• Cdk2 suppresses cellular senescence induced by the c-myc oncogene

  2010cited by this paper
• Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model

  2010cited by this paper
• Differential expression analysis for sequence count data

  2010cited by this paper
• A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering

  2009cited by this paper
• TopHat: discovering splice junctions with RNA-Seq

  2009cited by this paper
• Direct multiplexed measurement of gene expression with color-coded probe pairs

  2008cited by this paper
• Model-based Analysis of ChIP-Seq (MACS)

  2008cited by this paper
• Global Regulation of Nucleotide Biosynthetic Genes by c-Myc

  2008cited by this paper
• Myc's broad reach.

  2008cited by this paper
• Mapping and quantifying mammalian transcriptomes by RNA-Seq

  2008cited by this paper
• Regulating B‐cell activation and survival in response to TLR signals

  2007cited by this paper
• RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo

  2007cited by this paper
• Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

  2007cited by this paper
• Myc-binding-site recognition in the human genome is determined by chromatin context

  2006cited by this paper
• Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays

  2006cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation.

  2004cited by this paper
• Myc‐induced proliferation and transformation require Akt‐mediated phosphorylation of FoxO proteins

  2004cited by this paper
• Genomic targets of the human c-Myc protein.

  2003cited by this paper
• Dissecting p53 tumor suppressor functions in vivo.

  2002cited by this paper
• Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes

  2002cited by this paper
• Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.

  2001cited by this paper
• Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

  2001cited by this paper
• c-Myc regulates mammalian body size by controlling cell number but not cell size

  2001cited by this paper
• Cell cycle activation by c‐myc in a Burkitt lymphoma model cell line

  2000cited by this paper
• c-Myc enhances protein synthesis and cell size during B lymphocyte development.

  1999cited by this paper
• Control of cell growth by c-Myc in the absence of cell division.

  1999cited by this paper
• A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

  1995cited by this paper
• Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

  1990cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• New cell cycle compartments identified by multiparameter flow cytometry.

  1980cited by this paper

• Methionine metabolism and the NOP2 methyltransferase are essential for MYC-Driven liver tumorigenesis

  2026cites this paper
• MYC-positive follicular lymphoma complicated by refractory lactate and clonal evolution: a case report

  2026cites this paper
• Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer

  2026cites this paper
• MicroRNAs in type 2 diabetes mellitus and its cardiovascular complications: mechanistic insights and translational potential.

  2026cites this paper
• Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity

  2025cites this paper
• MYC-mediated transcriptional control of splicing factors promotes RNA splicing in activated B lymphocytes

  2025cites this paper
• The evolutionary foundations of transcriptional regulation in animals

  2025cites this paper
• Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer.

  2025cites this paper
• Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia

  2025cites this paper
• Probing the Structural Dynamics of the Unbound MAX Protein: Insights from Well-Tempered Metadynamics

  2025cites this paper
• MYC Binding Near Transcriptional End Sites Regulates Basal Gene Expression, Read‐Through Transcription, and Intragenic Contacts

  2025cites this paper
• Renal Coenzyme A (CoA) Production Fuels Stem Cell Proliferation and Tumor Growth

  2025cites this paper
• Integrative characterization of MYC RNA-binding function

  2025cites this paper
• MYC and AP-1 oncogenes synergistically bind enhancers to rewire transcription

  2025cites this paper
• DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition

  2025cites this paper
• Mechanistic analysis of compounds that modulate VEGF-A splicing in podocytes with therapeutic potential for diabetic nephropathy

  2025cites this paper
• Targeting the undruggable MYC in cancer: the rationale of using XPO1 inhibitors

  2025cites this paper
• The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia

  2025cites this paper
• Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients

  2025cites this paper
• Regulatory role of transcription factor c-Myc in the pathogenesis of psoriasis

  2025cites this paper
• Senataxin prevents replicative stress induced by the Myc oncogene

  2025cites this paper
• The m6A reader YTHDF1 facilitates nasopharyngeal carcinoma proliferation and migration via c-MYC

  2025cites this paper
• Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation

  2025cites this paper
• C‐Myc Indirectly Controls ATP13A2 Levels via HIF‐1α Activation

  2025cites this paper
• MYC: The Guardian of Its Own Chaos

  2025cites this paper
• Steering research on mRNA splicing in cancer towards clinical translation

  2024cites this paper
• MYC-Targeting Inhibitors Generated from a Stereodiversified Bicyclic Peptide Library

  2024cites this paper
• The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage

  2024cites this paper
• CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts

  2024cites this paper
• ZNF143 binds DNA and stimulates transcripstion initiation to activate and repress direct target genes

  2024cites this paper
• Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo.

  2024cites this paper
• MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development

  2024cites this paper
• The Functional Interaction Between Epstein–Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma

  2024cites this paper
• Tolerance of Oncogene-Induced Replication Stress: A Fuel for Genomic Instability

  2024cites this paper
• Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells

  2024cites this paper
• Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models

  2024cites this paper
• ZNF143 binds DNA and stimulates transcription initiation to activate and repress direct target genes

  2024cites this paper
• Transcriptional regulation by MYC: an emerging new model

  2024influential citation
• Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II

  2024cites this paper
• MYC activity at enhancers drives prognostic transcriptional programs through an epigenetic switch

  2024cites this paper
• MYC phase separation selectively modulates the transcriptome

  2024cites this paper
• MYCN in neuroblastoma: the kings' new clothes and drugs

  2024cites this paper
• MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration

  2023cites this paper
• c-Myc inhibits LAPTM5 expression in B-cell lymphomas

  2023cites this paper
• Lessons in aging from Myc knockout mouse models

  2023cites this paper
• Z-ligustilide preferentially caused mitochondrial dysfunction in AML HL-60 cells by activating nuclear receptors NUR77 and NOR1

  2023cites this paper
• MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study

  2023cites this paper
• Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers

  2023cites this paper
• Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers

  2023cites this paper
• Protein arginine methyltransferase 1 regulates B cell fate after positive selection in the germinal center in mice

  2023cites this paper
• MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products

  2023cites this paper
• MYC promotes global transcription in part by controlling P-TEFb complex formation via DNA-binding independent inhibition of CDK9 SUMOylation

  2023cites this paper
• MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma

  2023cites this paper
• Intrinsically disordered regions in the transcription factor MYC:MAX provide DNA selectivity via intramolecular interactions

  2023cites this paper
• CRISPR/Cas9 screen for genome‐wide interrogation of essential MYC‐bound E‐boxes in cancer cells

  2023cites this paper
• Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis

  2023cites this paper
• MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells

  2023cites this paper
• E-box binding transcription factors in cancer

  2023cites this paper
• MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint

  2023cites this paper
• MYC determines lineage commitment in kras driven primary liver cancer development.

  2023cites this paper
• Demystifying the Druggability of the MYC Family of Oncogenes.

  2023cites this paper
• HAND2 assists MYCN enhancer invasion to regulate a noradrenergic neuroblastoma phenotype.

  2023cites this paper
• MYC enhancer invasion promotes prognostic cancer type-specific gene programs through an epigenetic switch

  2023influential citation
• Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma

  2023cites this paper
• Defining transcription factor nucleosome binding with Pioneer-seq

  2023cites this paper
• Cell-to-cell variability in Myc dynamics drives transcriptional heterogeneity in cancer cells.

  2023cites this paper
• The MYC-regulated lncRNA LNROP (ENSG00000254887) enables MYC-driven cell proliferation by controlling the expression of OCT2

  2023cites this paper
• The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme

  2023cites this paper
• The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival

  2023cites this paper
• Lymphoma dissemination is a pathological hallmark for malignant progression of B-cell lymphoma

  2023cites this paper
• Intrinsically disordered regions in the transcription factor MYC:MAX modulate DNA binding via intramolecular interactions

  2023cites this paper
• Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer

  2023cites this paper
• MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis

  2023cites this paper
• The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma

  2023cites this paper
• MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis

  2023cites this paper
• ZNF692 organizes a hub specialized in 40S ribosomal subunit maturation enhancing translation in rapidly proliferating cells

  2023cites this paper
• MYC overexpression leads to increased chromatin interactions at super-enhancers and MYC binding sites

  2022cites this paper
• Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

  2022cites this paper
• False-positive IRESes from Hoxa9 and other genes resulting from errors in mammalian 5′ UTR annotations

  2022cites this paper
• MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, and enhances the viral infection of Burkitt lymphoma cells

  2022cites this paper
• Effects of Cinobufagin on the Proliferation, Migration, and Invasion of H1299 Lung Cancer Cells

  2022cites this paper
• Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis

  2022cites this paper
• MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes

  2022cites this paper
• Pharmacologic Inhibition of DYRK1A Results in MYC Hyperactivation and ERK Hyperphosphorylation rendering KMT2A-R ALL Cells Sensitive to BCL2 Inhibition

  2022cites this paper
• Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma

  2022cites this paper
• Widespread hypertranscription in aggressive human cancers

  2022cites this paper
• MYC and therapy resistance in cancer: risks and opportunities

  2022cites this paper
• Significant position of C-myc in colorectal cancer: a promising therapeutic target

  2022cites this paper
• MYC sensitises cells to apoptosis by driving energetic demand

  2022cites this paper
• TXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding

  2022cites this paper
• The glycolytic enzyme ALDOA and the exon junction complex protein RBM8A are regulators of ribosomal biogenesis

  2022cites this paper
• Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability

  2022cites this paper
• ZNF692 organizes a hub for ribosome maturation enhancing translation in rapidly proliferating cells

  2022cites this paper
• Research progress on the interaction between long non-coding RNAs and RNA-binding proteins to influence the reprogramming of tumor glucose metabolism

  2022cites this paper
• A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression

  2022cites this paper
• A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites

  2022cites this paper
• Altered pathways and targeted therapy in double hit lymphoma

  2022cites this paper
• Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)

  2022cites this paper
• MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

  2022cites this paper
• Deep learning for MYC binding site recognition

  2022cites this paper